(Q33966821)

30 July 2017

1 reference

title

Understanding and managing cancer cachexia (English)

1 reference

30 July 2017

Vera C Mazurak

3

0 references

Alexandra M Easson

object named as

Alexandra M Easson

2

0 references

Vickie E. Baracos

object named as

Vickie E Baracos

5

0 references

author name string

Neil MacDonald

1

1 reference

30 July 2017

Geoffrey P Dunn

4

1 reference

30 July 2017

publication date

1 July 2003

1 reference

Journal of the American College of Surgeons

30 July 2017

published in

1 reference

30 July 2017

volume

197

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

143-161

1 reference

The role of tube feeding and total parenteral nutrition in advanced illness.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Clinical survival predictors in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Hypercatabolism and hypermetabolism in wasting states

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Cancer cachexia: from experimental models to patient management

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

The role of cytokines in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Cachexia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

1 reference

7 January 2021

Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

A sarcoma-derived protein regulates hepatocyte metabolism via autocrine production of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Eicosanoid-dependent cancer cachexia and wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Dietary modification of inflammation with lipids.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

The 'cancer cachectic factor'.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Thalidomide in patients with cachexia due to terminal cancer: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Thalidomide in cancer treatment: a potential role in the elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Induction of muscle protein degradation by a tumour factor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Mechanism of muscle protein degradation induced by a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Increased muscle ubiquitin mRNA levels in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Identification of ubiquitin ligases required for skeletal muscle atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Nuclear factor kappa B signaling in catabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Differential anabolic effects of testosterone and amino acid feeding in older men.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of glutamine supplementation on protein metabolism and glutathione in tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

On appetite and its loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Body-composition changes in patients who gain weight while receiving megestrol acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Acute-phase protein response and survival duration of patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Angiotensin-converting enzyme 2--a new cardiac regulator

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Modulatory effect of antibiotics on cytokine production by human monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Therapeutic effect of clarithromycin on a transplanted tumor in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Creatine supplementation influences substrate utilization at rest

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effects of creatine supplementation on body composition, strength, and sprint performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Oral creatine supplementation and athletic performance: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effects of creatine supplementation on muscle power, endurance, and sprint performance

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Creatine supplementation improves muscular performance in older men.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Androgen supplementation in older women: too much hype, not enough data

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Serum androgens and gonadotrophins in bronchial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Short-term oxandrolone administration stimulates net muscle protein synthesis in young men.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Relationship between fatty acid accretion, membrane composition, and biologic functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

More good news about fish oil.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

A phase II study of low-dose megestrol acetate using twice-daily dosing for anorexia in nonhormonally dependent cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Hormonal regulation of appetite and body mass in patients with advanced prostate cancer treated with combined androgen blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Treatment with growth hormone and insulin-like growth factor-I in critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Chronic heart failure and skeletal muscle catabolism: effects of exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Disordered metabolic response with cancer and its management

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Cytokines, apoptosis and cachexia: the potential for TNF antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Cachexia: a therapeutic approach beyond cytokine antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Oral creatine supplementation and skeletal muscle metabolism in physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Clinical treatment regimens for chronic heart failure: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Adenosine triphosphate for cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

Epoetin alfa for protection of metabolic and exercise capacity in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900382-X

7 January 2021

10.1016/S1072-7515(03)00382-X

Identifiers

DOI

1 reference

30 July 2017

1 reference